COPD Biologics in Practice: Exacerbation Reduction is No Longer Enough
Consultant Live,
The story of biologic therapy in airway disease is, at its core, a story of expanding possibility — and expanding complexity.
Eosinophils, Exacerbations, and Endpoints: Biologic Therapy Selection in COPD and Asthma
Consultant Live,
The landscape of airway disease management has been fundamentally altered by the arrival of biologic therapies targeting type 2 …
Small Airway Mucus Plugging in Severe Asthma: Insights and Implications
HCP Live,
Stephen Schworer, MD, PhD Credit: American Lung Association Asthma is a common, chronic obstructive airway disease…